These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6707634)

  • 1. Solubilization and characterization of striatal dopamine receptors.
    Lew JY; Goldstein M
    J Neurochem; 1984 May; 42(5):1298-305. PubMed ID: 6707634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1985 May; 37(5):320-8. PubMed ID: 2862240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist binding promotes a guanine nucleotide reversible increase in the apparent size of the bovine anterior pituitary dopamine receptors.
    Kilpatrick BF; Caron MG
    J Biol Chem; 1983 Nov; 258(22):13528-34. PubMed ID: 6643440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential adsorption of dopamine antagonist binding sites by fluphenazine-agarose.
    Fong JC
    Proc Natl Sci Counc Repub China B; 1986 Apr; 10(2):113-7. PubMed ID: 3749364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK; Ross GM; Bajwa SB; Mishra RK
    Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
    Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK
    J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor of the porcine anterior pituitary gland. Solubilization and characterization.
    Kilpatrick BF; Caron MG
    Biochem Pharmacol; 1984 Jun; 33(12):1981-8. PubMed ID: 6547344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
    Zhang X; Segawa T
    Eur J Pharmacol; 1989 Aug; 166(3):401-10. PubMed ID: 2680521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization of D2 dopamine receptor coupled to guanine nucleotide regulatory protein from bovine striatum.
    Kuno T; Saijoh K; Tanaka C
    J Neurochem; 1983 Sep; 41(3):841-7. PubMed ID: 6308173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB; Otsuka NY; Dumbrille-Ross A; Grigoriadis D; Tirpak A; Seeman P
    J Biol Chem; 1986 Jun; 261(18):8397-406. PubMed ID: 3522568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization of striatal D-2 dopamine receptors: evidence that apparent loss during aging is not due to membrane sequestration.
    Henry JM; Roth GS
    J Gerontol; 1986 Mar; 41(2):129-35. PubMed ID: 3005385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
    Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary.
    Dumbrille-Ross A; Seeman P
    Biochem Pharmacol; 1987 Jul; 36(13):2095-9. PubMed ID: 2955789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of neuroleptic/dopamine receptors of human brain striatum.
    Davis A; Madras B; Seeman P
    Eur J Pharmacol; 1981 Mar; 70(3):321-9. PubMed ID: 6112153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of pergolide with central dopaminergic receptors.
    Goldstein M; Lieberman A; Lew JY; Asano T; Rosenfeld MR; Makman MH
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3725-8. PubMed ID: 6932044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of the D-2 dopamine receptor from bovine striatum.
    Elazar Z; Kanety H; David C; Fuchs S
    Biochem Biophys Res Commun; 1988 Oct; 156(1):602-9. PubMed ID: 2972288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxy-1-propanesulfonate.
    Poyner DR; Birdsall NJ; Curtis C; Eveleigh P; Hulme EC; Pedder EK; Wheatley M
    Mol Pharmacol; 1989 Sep; 36(3):420-9. PubMed ID: 2506431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
    Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
    Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE; Zaczek R; Pearsall DM; De Souza EB
    Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.